Laboratory Corp Of America Holdings (NYSE:LH) Quarterly Sentiment Report

July 16, 2018 - By Ash Maslow

Laboratory Corporation of America Holdings (NYSE:LH) Logo

Sentiment for Laboratory Corp Of America Holdings (NYSE:LH)

Laboratory Corp Of America Holdings (NYSE:LH) institutional sentiment decreased to 1.08 in 2018 Q1. Its down -0.12, from 1.2 in 2017Q4. The ratio turned negative, as 280 investment professionals increased or started new equity positions, while 259 sold and reduced stock positions in Laboratory Corp Of America Holdings. The investment professionals in our partner’s database now hold: 91.81 million shares, up from 91.47 million shares in 2017Q4. Also, the number of investment professionals holding Laboratory Corp Of America Holdings in their top 10 equity positions decreased from 13 to 12 for a decrease of 1. Sold All: 26 Reduced: 233 Increased: 206 New Position: 74.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory firm worldwide. The company has market cap of $19.09 billion. It operates through two divisions, LabCorp Diagnostics and Covance Drug Development. It has a 15.37 P/E ratio. The firm offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, tests for sexually-transmitted diseases, HCV tests, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens.

The stock decreased 0.32% or $0.595 during the last trading session, reaching $186.615. About 207,920 shares traded. Laboratory Corporation of America Holdings (NYSE:LH) has risen 28.45% since July 16, 2017 and is uptrending. It has outperformed by 15.88% the S&P500.

Analysts await Laboratory Corporation of America Holdings (NYSE:LH) to report earnings on July, 25. They expect $2.92 EPS, up 18.22 % or $0.45 from last year’s $2.47 per share. LH’s profit will be $298.72 million for 15.98 P/E if the $2.92 EPS becomes a reality. After $2.78 actual EPS reported by Laboratory Corporation of America Holdings for the previous quarter, Wall Street now forecasts 5.04 % EPS growth.

Veritas Investment Management Llp holds 6.97% of its portfolio in Laboratory Corporation of America Holdings for 336,370 shares. Bridger Management Llc owns 614,622 shares or 6.03% of their US portfolio. Moreover, Healthcor Management L.P. has 5.78% invested in the company for 1.05 million shares. The New York-based Allen Investment Management Llc has invested 5.34% in the stock. Weitz Investment Management Inc., a Nebraska-based fund reported 747,684 shares.

Since January 1, 0001, it had 0 insider buys, and 12 sales for $34.00 million activity.

Laboratory Corporation of America Holdings (NYSE:LH) Ratings Coverage

Ratings analysis reveals 73% of Laboratory Corp’s analysts are positive. Out of 15 Wall Street analysts rating Laboratory Corp, 11 give it “Buy”, 0 “Sell” rating, while 4 recommend “Hold”. The lowest target is $176.0 while the high is $210. The stock’s average target of $194.43 is 4.19% above today’s ($186.615) share price. LH was included in 19 notes of analysts from January 24, 2018. The firm has “Outperform” rating by Credit Suisse given on Thursday, March 8. The rating was maintained by Craig Hallum on Wednesday, February 7 with “Buy”. The rating was maintained by Robert W. Baird with “Hold” on Thursday, February 8. The stock of Laboratory Corporation of America Holdings (NYSE:LH) has “Hold” rating given on Tuesday, March 6 by Jefferies. On Tuesday, May 1 the stock rating was reinitiated by Robert W. Baird with “Outperform”. Credit Suisse maintained Laboratory Corporation of America Holdings (NYSE:LH) on Thursday, March 1 with “Outperform” rating. The company was maintained on Friday, February 9 by Citigroup. Mizuho maintained Laboratory Corporation of America Holdings (NYSE:LH) on Wednesday, January 24 with “Hold” rating. On Thursday, June 7 the stock rating was upgraded by KeyBanc Capital Markets to “Buy”. Piper Jaffray maintained it with “Buy” rating and $194.0 target in Tuesday, February 6 report.

Another recent and important Laboratory Corporation of America Holdings (NYSE:LH) news was published by Streetinsider.com which published an article titled: “Lab Corp. (LH) Detected Suspicious Activity on its Information Technology Network” on July 16, 2018.

Laboratory Corporation of America Holdings (NYSE:LH) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.